TY - JOUR
T1 - Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM
AU - Slart, Riemer H. J. A.
AU - Glaudemans, Andor W. J. M.
AU - Gheysens, Olivier
AU - Lubberink, Mark
AU - Kero, Tanja
AU - Dweck, Marc R.
AU - Habib, Gilbert
AU - Gaemperli, Oliver
AU - Saraste, Antti
AU - Gimelli, Alessia
AU - Georgoulias, Panagiotis
AU - Verberne, Hein J.
AU - Bucerius, Jan
AU - Rischpler, Christoph
AU - Hyafil, Fabien
AU - 4Is Cardiovascular Imaging: a joint initiative of the European Association of Cardiovascular Imaging (EACVI)
AU - the European Association of Nuclear Medicine (EANM)
AU - Erba, Paola A.
N1 - Funding Information: We thank the EANM Committees, EANM National Societies, and the EACVI bodies for their review and contribution. We acknowledge the contribution of previous guidelines on which the present are based (1 , 8 , 13 , 14). This guideline summarizes the views of the EANM Cardiovascular and Infection & Inflammation Committees and the EACVI. It reflects recommendations for which the EANM and the EACVI cannot be held responsible. The recommendations should be taken into context of good practice of nuclear medicine and do not substitute for national and international legal or regulatory provisions. Publisher Copyright: © 2020, The Author(s).
PY - 2021/4
Y1 - 2021/4
N2 - With this document, we provide a standard for PET/(diagnostic) CT imaging procedures in cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with dysfunctional innervation (4Is). This standard should be applied in clinical practice and integrated in clinical (multicenter) trials for optimal procedural standardization. A major focus is put on procedures using [18F]FDG, but 4Is PET radiopharmaceuticals beyond [18F]FDG are also described in this document. Whilst these novel tracers are currently mainly applied in early clinical trials, some multicenter trials are underway and we foresee in the near future their use in clinical care and inclusion in the clinical guidelines. Finally, PET/MR applications in 4Is cardiovascular diseases are also briefly described. Diagnosis and management of 4Is-related cardiovascular diseases are generally complex and often require a multidisciplinary approach by a team of experts. The new standards described herein should be applied when using PET/CT and PET/MR, within a multimodality imaging framework both in clinical practice and in clinical trials for 4Is cardiovascular indications.
AB - With this document, we provide a standard for PET/(diagnostic) CT imaging procedures in cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with dysfunctional innervation (4Is). This standard should be applied in clinical practice and integrated in clinical (multicenter) trials for optimal procedural standardization. A major focus is put on procedures using [18F]FDG, but 4Is PET radiopharmaceuticals beyond [18F]FDG are also described in this document. Whilst these novel tracers are currently mainly applied in early clinical trials, some multicenter trials are underway and we foresee in the near future their use in clinical care and inclusion in the clinical guidelines. Finally, PET/MR applications in 4Is cardiovascular diseases are also briefly described. Diagnosis and management of 4Is-related cardiovascular diseases are generally complex and often require a multidisciplinary approach by a team of experts. The new standards described herein should be applied when using PET/CT and PET/MR, within a multimodality imaging framework both in clinical practice and in clinical trials for 4Is cardiovascular indications.
KW - 4Is
KW - Cardiovascular diseases
KW - PET/CT
KW - Procedural recommendations
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85094146711&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/33106926
U2 - https://doi.org/10.1007/s00259-020-05066-5
DO - https://doi.org/10.1007/s00259-020-05066-5
M3 - Article
C2 - 33106926
SN - 1619-7070
VL - 48
SP - 1016
EP - 1039
JO - European journal of nuclear medicine and molecular imaging
JF - European journal of nuclear medicine and molecular imaging
IS - 4
ER -